Browsing Tag
Indian pharmaceutical sector
1 post
Why Hester Biosciences’ trading window closure matters for investors chasing momentum in NSE: HESTERBIO
Hester Biosciences (NSE: HESTERBIO) has closed its trading window ahead of Q2 results. At ₹1,920 and 47x P/E, can the stock sustain its premium?